Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC5A2 | P31639 | 5/20 | 0.54 |
| ▸ | SLC5A1 | P13866 | 4/20 | 0.54 |
| ▸ | TYR | P14679 | 1/20 | 0.48 |
| ▸ | SELP | P16109 | 2/20 | 0.48 |
| ▸ | SELPLG | Q14242 | 1/20 | 0.48 |
| ▸ | SLC28A3 | Q9HAS3 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7028761 | 1.00 | SLC5A2 (0.54) | SLC5A2SLC5A1TYRSELPSELPLG | |
| SCHEMBL7033566 | 0.95 | SLC5A2 (0.56) | SLC5A2SLC5A1TYRSELPSELPLG | |
| SCHEMBL7033574 | 0.95 | SLC5A2 (0.56) | SLC5A2SLC5A1TYRSELPSELPLG | |
| SCHEMBL7033407 | 0.86 | TYR (0.49) | SLC5A2SLC5A1TYRNPC1RAB9A | |
| SCHEMBL7036101 | 0.86 | TYR (0.49) | SLC5A2SLC5A1TYRNPC1RAB9A | |
| SCHEMBL14120495 | 0.85 | SELP (0.62) | TYRSELPSELPLGSLC28A3NPC1 | |
| SCHEMBL14120492 | 0.85 | SELP (0.62) | TYRSELPSELPLGSLC28A3NPC1 | |
| SCHEMBL13272303 | 0.84 | TYR (0.50) | TYR | |
| SCHEMBL7038463 | 0.82 | SLC28A3 (0.47) | SLC5A2SLC5A1TYRSLC28A3NPC1 | |
| SCHEMBL987985 | 0.81 | ACHE (0.61) | TYRSLC28A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0758243-B1 | BINDING OF E-SELECTIN, P-SELECTIN OR L-SELECTIN TO SIALYL-LEWISx OR SIALYL-LEWISa | TEXAS BIOTECHNOLOGY CORP (US) | 2003-03-12 | — | — | EP | disclosed |